Brief: Stoke Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Business Updates

Stoke Therapeutics

10/03/2022 12:39

March 10 (Reuters) - Stoke Therapeutics Inc  STOK.O :
    * STOKE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
    * Q4 LOSS PER SHARE $0.66
    * BELIEVE WE ARE WELL-POSITIONED TO CONTINUE TO EXECUTE ON
OUR
GOALS FOR 2022
    * STOKE THERAPEUTICS - EXPECTS CASH, CASH EQUIVALENTS,
MARKETABLE
SECURITIES, RESTRICTED CASH AS OF DEC 31, 2021 TO BE SUFFICIENT
TO FUND OPERATIONS INTO H2 2024
    * Q4 EARNINGS PER SHARE VIEW $-0.62 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw72k9zWa 
Further company coverage:  STOK.O